• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Accenture launches Cloud for R&D, forms Cloud Coalition

Accenture launches Cloud for R&D, forms Cloud Coalition

October 15, 2014
CenterWatch Staff

Accenture, an Ireland-based global management consulting, technology services and outsourcing company, has launched Accenture Life Sciences Cloud for R&D, which speeds clinical development, helps improve patient outcomes and creates greater R&D efficiency through a new single analytics platform that brings together multiple internal and external data sources across clinical, safety, regulatory and operational functions.

In parallel with the R&D platform, Accenture has formed a Life Sciences Cloud Coalition, which includes Eisai, Merck and Pfizer. The aim of this group is to collaborate to bring innovation to the Accenture Life Sciences Cloud and digitally enable the R&D function, speed up the drug development process and improve quality and cost for the industry.

The Accenture Life Sciences Cloud for R&D is part of Accenture Accelerated R&D Services, a business service focused on building more efficient and effective R&D models, partnering with the industry from early clinical trials to regulatory approvals and throughout the product lifecycle.

"With the cost of healthcare—particularly for drug development—escalating faster than the gross domestic product of nearly every economy around the world, pharmaceutical companies are facing huge pressure to seek efficiencies in R&D," said Kevin Julian, managing director of Accenture Accelerated R&D Services. "New technologies, analytic capabilities and a willingness by drug manufacturers to collaborate can help mitigate rising costs. These can be leveraged to provide a much clearer view of the clinical results by collecting and analyzing data and information in real time—beginning with the development cycle."

The foundation of the Accenture Life Sciences Cloud for R&D is an alliance between Accenture and Oracle. The solutions developed by the alliance are built on a combination of Oracle's experience in developing and hosting mission-critical Clinical Data Warehousing and analytics applications for life sciences, coupled with Accenture's experience delivering best-in-class service-based solutions. The Accenture Life Sciences Cloud for R&D utilizes Oracle datacenters around the globe to host clinical applications such as Oracle Life Sciences Data Hub and Oracle Clinical Development Analytics.

Key features of the Accenture Life Sciences Cloud for R&D include:

  • Clinical Trial and Scientific Data Warehouse for storing, managing, searching and reporting on patient data to improve strategic decision making, including spotting promising drugs earlier and decreasing investment in drugs that may not succeed.
  • Operational Data Warehouse for gathering vital metrics to monitor clinical trial portfolios, manage vendor relationships and address any operational issues.
  • Information eXchange Hub to provide an integration and security layer to manage users, data sources, on-premise systems and other cloud providers to support a virtual, seamless aggregation of data.
  • Scalable, secure, regulatory-compliant cloud platform utilizing Oracle Engineered Systems hosted in Oracle datacenters. The platform is available as a private cloud and designed for both large- and small-scale implementations with the ability to handle high data volumes and service level requirements.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing